MedTrace Logo

Alive & Thrive Nigeria Impact Evaluation

NCT02975063 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15169

Last updated 2021-01-14

No results posted yet for this study

Summary

Investigators will use a cluster-randomized design to evaluate the overall impact of the Alive \& Thrive infant and young child feeding communication strategies in Lagos and Kaduna States, Nigeria. The impact in each state and in a subset of urban local government areas (LGAs) will also be tested.This is a mixed methods evaluation; the quantitative data will be complemented by qualitative data obtained from different groups targeted by or involved in the program.

Conditions

  • Complementary Feeding

Interventions

BEHAVIORAL

A&T IYCF intervention

(1) Interpersonal communication through frontline workers/volunteers to increase mothers' knowledge and practice of optimal infant and young child feeding (IYCF) behaviors. Interpersonal communication will involve multiple contacts with mothers and an array of IYCF messages; (2) Community mobilization activities to raise awareness of the benefits of optimal IYCF practices among opinion leaders and family members, and increase their support to mother for IYCF; (3) Training of facility and community-based health workers on IYCF to improve their ability to support mothers and provide timely information on IYCF; and (4) Mass media communication on IYCF.

Sponsors & Collaborators

  • FHI 360

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    collaborator OTHER

  • TNS RMS Nigeria, Ltd.

    collaborator UNKNOWN

  • RTI International

    lead OTHER

Principal Investigators

  • Valerie Flax · RTI International

  • Mariam Fagbemi · TNS RMS Nigeria, Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-19
Primary Completion
2020-12-02
Completion
2020-12-02

Countries

  • Nigeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02975063 on ClinicalTrials.gov